To protect the security of personal information, your Internet browser will need to be upgraded to access this website. Please ensure you use the latest version of:

Internet Explorer

Microsoft Edge

Mozilla Firefox

Google Chrome


Pharmacy Asymptomatic Testing Program

As of October 20, 2020, Alberta is pausing asymptomatic COVID-19 testing to those with no COVID-19 exposure.

Group Benefits


White papers

Drug pipeline, what lies ahead for private plans

Every year, advancements and innovations in drug therapies provide important, life-changing treatments for plan members. However, with many new therapies being higher in cost, significant pressure has been placed on the sustainability of private drugs plans. This report highlights some new and notable developments in the drug pipeline to provide insight into what may lie ahead for your benefit plan and your employees.